A theme aimed at commercializing the ALS drug candidate KP2011 by pursuing development in North America, Europe, India and China, with a view to entering into licensing agreements with pharmaceutical companies and others. This also includes intellectual property developments supporting overseas expansion, such as allowance of a U.S. patent.